Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiology | 3 | 2021 | 474 | 1.000 |
Why?
|
| Exercise Test | 2 | 2016 | 239 | 0.800 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 141 | 0.590 |
Why?
|
| Crowdsourcing | 1 | 2018 | 14 | 0.580 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2019 | 112 | 0.560 |
Why?
|
| Acute Coronary Syndrome | 1 | 2020 | 193 | 0.540 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 314 | 0.540 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 195 | 0.530 |
Why?
|
| Aortic Diseases | 1 | 2019 | 162 | 0.520 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 532 | 0.490 |
Why?
|
| Periodicals as Topic | 1 | 2018 | 177 | 0.480 |
Why?
|
| Consensus | 1 | 2018 | 543 | 0.470 |
Why?
|
| Ventricular Dysfunction | 1 | 2015 | 25 | 0.450 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 465 | 0.450 |
Why?
|
| Thrombosis | 1 | 2019 | 500 | 0.420 |
Why?
|
| Coronary Angiography | 2 | 2016 | 442 | 0.420 |
Why?
|
| Fontan Procedure | 1 | 2016 | 187 | 0.400 |
Why?
|
| Down Syndrome | 1 | 2016 | 201 | 0.400 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 294 | 0.390 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2016 | 269 | 0.380 |
Why?
|
| Tachycardia, Ventricular | 1 | 2015 | 254 | 0.370 |
Why?
|
| Chest Pain | 1 | 2012 | 93 | 0.360 |
Why?
|
| Arterial Pressure | 1 | 2012 | 123 | 0.360 |
Why?
|
| Hypertension, Pulmonary | 2 | 2016 | 443 | 0.360 |
Why?
|
| Pediatrics | 1 | 2021 | 1202 | 0.350 |
Why?
|
| Heart Ventricles | 1 | 2016 | 750 | 0.350 |
Why?
|
| Heart Defects, Congenital | 5 | 2020 | 1843 | 0.340 |
Why?
|
| Electrocardiography | 1 | 2016 | 918 | 0.330 |
Why?
|
| Echocardiography | 4 | 2020 | 1097 | 0.300 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 445 | 0.300 |
Why?
|
| Heart Diseases | 1 | 2012 | 486 | 0.270 |
Why?
|
| Heart Septal Defects | 2 | 2018 | 36 | 0.260 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 1032 | 0.240 |
Why?
|
| Child | 11 | 2021 | 25061 | 0.240 |
Why?
|
| LIM Domain Proteins | 2 | 2014 | 65 | 0.200 |
Why?
|
| Heart Failure | 1 | 2015 | 2172 | 0.180 |
Why?
|
| Heart Murmurs | 1 | 2021 | 12 | 0.180 |
Why?
|
| Humans | 20 | 2021 | 126020 | 0.170 |
Why?
|
| Job Application | 1 | 2021 | 21 | 0.170 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2021 | 84 | 0.170 |
Why?
|
| Brain Infarction | 1 | 2020 | 28 | 0.160 |
Why?
|
| Physical Examination | 1 | 2021 | 160 | 0.160 |
Why?
|
| Myxoma | 1 | 2020 | 29 | 0.160 |
Why?
|
| DiGeorge Syndrome | 1 | 2020 | 79 | 0.160 |
Why?
|
| Education, Distance | 1 | 2020 | 65 | 0.160 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 142 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 576 | 0.160 |
Why?
|
| Career Choice | 1 | 2021 | 155 | 0.150 |
Why?
|
| Hospitals, Pediatric | 2 | 2016 | 776 | 0.150 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 104 | 0.150 |
Why?
|
| Tetralogy of Fallot | 1 | 2020 | 173 | 0.140 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 194 | 0.140 |
Why?
|
| Male | 8 | 2020 | 62050 | 0.140 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 203 | 0.130 |
Why?
|
| Aortic Valve | 1 | 2020 | 411 | 0.130 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2018 | 137 | 0.130 |
Why?
|
| Learning | 1 | 2020 | 355 | 0.130 |
Why?
|
| Thrombolytic Therapy | 1 | 2019 | 202 | 0.130 |
Why?
|
| Aorta | 1 | 2020 | 498 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 1845 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2020 | 1018 | 0.130 |
Why?
|
| Infant | 4 | 2020 | 12762 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2020 | 16753 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 393 | 0.120 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 1349 | 0.120 |
Why?
|
| Risk Factors | 3 | 2016 | 10386 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 848 | 0.110 |
Why?
|
| Vascular Resistance | 1 | 2016 | 185 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2021 | 526 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 190 | 0.110 |
Why?
|
| Muscle, Striated | 1 | 2014 | 9 | 0.110 |
Why?
|
| Enalapril | 1 | 2014 | 13 | 0.110 |
Why?
|
| Captopril | 1 | 2014 | 23 | 0.110 |
Why?
|
| ROC Curve | 1 | 2016 | 569 | 0.110 |
Why?
|
| Muscle Proteins | 2 | 2014 | 397 | 0.110 |
Why?
|
| Airway Obstruction | 1 | 2016 | 176 | 0.100 |
Why?
|
| Internship and Residency | 2 | 2021 | 1194 | 0.100 |
Why?
|
| Infant, Newborn | 4 | 2021 | 8357 | 0.100 |
Why?
|
| Myocarditis | 1 | 2015 | 124 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1024 | 0.100 |
Why?
|
| Female | 9 | 2020 | 67877 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 203 | 0.100 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2012 | 39 | 0.090 |
Why?
|
| Angina Pectoris | 1 | 2012 | 51 | 0.090 |
Why?
|
| Vasoconstriction | 1 | 2012 | 92 | 0.090 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2012 | 42 | 0.090 |
Why?
|
| Adolescent | 3 | 2016 | 19936 | 0.090 |
Why?
|
| Palliative Care | 1 | 2016 | 438 | 0.090 |
Why?
|
| Heart Conduction System | 1 | 2012 | 151 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2015 | 552 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 474 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3904 | 0.080 |
Why?
|
| Survival Rate | 1 | 2016 | 2059 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 3679 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5049 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 493 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2018 | 1124 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 726 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2014 | 762 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2014 | 477 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 2011 | 184 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2012 | 391 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2012 | 556 | 0.070 |
Why?
|
| Brain | 1 | 2020 | 3032 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2015 | 863 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 1210 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2011 | 507 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 609 | 0.070 |
Why?
|
| Texas | 1 | 2016 | 3532 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2179 | 0.060 |
Why?
|
| Age Factors | 1 | 2012 | 2770 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2018 | 12310 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2016 | 2965 | 0.050 |
Why?
|
| Prognosis | 1 | 2012 | 4707 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2014 | 4471 | 0.050 |
Why?
|
| Facial Paralysis | 1 | 2020 | 34 | 0.040 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 22 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2020 | 92 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2020 | 88 | 0.040 |
Why?
|
| Cell Line | 2 | 2014 | 2562 | 0.040 |
Why?
|
| Young Adult | 1 | 2012 | 9615 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2020 | 214 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2018 | 362 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2020 | 934 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 531 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 820 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 767 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1348 | 0.030 |
Why?
|
| Ankyrin Repeat | 1 | 2014 | 6 | 0.030 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2014 | 13 | 0.030 |
Why?
|
| Actinin | 1 | 2014 | 6 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 46 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 66 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 112 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 80 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 1174 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 402 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 352 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2012 | 10 | 0.020 |
Why?
|
| Connectin | 1 | 2012 | 28 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2012 | 39 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 414 | 0.020 |
Why?
|
| Azepines | 1 | 2012 | 61 | 0.020 |
Why?
|
| Creatinine | 1 | 2014 | 378 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 273 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1192 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 1206 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 1014 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6085 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1670 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 664 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3459 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1596 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6006 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2014 | 823 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 3388 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 1279 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 14330 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 33114 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 5928 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 17574 | 0.010 |
Why?
|